drugset / Trial / NCT01943812

Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

NCT01943812

Phase 4 Completed 287 enrolled Peter Humaidan
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss. Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.

Timeline

Start
2013-12
Primary completion
2019-04
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Background Estradiol Other / unclassified 6 mg
Background Progesterone Other / unclassified 180 mg